Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Titel:
Correction: Efficacy and safety of fremanezumab in clinical trial participants aged ≥60 years with episodic or chronic migraine: pooled results from 3 randomized, double-blind, placebo-controlled phase 3 studies
Auteur:
Nahas, Stephanie J. Naegel, Steffen Cohen, Joshua M. Ning, Xiaoping Janka, Lindsay Campos, Verena Ramirez Krasenbaum, Lynda J. Holle-Lee, Dagny Kudrow, David Lampl, Christian